Valproate Pregnancy Prevention Programme: temporary advice for management during coronavirus (COVID-19), MHRA

Guidance has been published to support initiation of valproate in female patients and for annual review and pregnancy testing during the coronavirus pandemic.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news